1. Home
  2. WVE vs SSYS Comparison

WVE vs SSYS Comparison

Compare WVE & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • SSYS
  • Stock Information
  • Founded
  • WVE 2012
  • SSYS 1989
  • Country
  • WVE Singapore
  • SSYS United States
  • Employees
  • WVE N/A
  • SSYS N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • SSYS Computer peripheral equipment
  • Sector
  • WVE Health Care
  • SSYS Technology
  • Exchange
  • WVE Nasdaq
  • SSYS Nasdaq
  • Market Cap
  • WVE 915.6M
  • SSYS 970.9M
  • IPO Year
  • WVE 2015
  • SSYS 1994
  • Fundamental
  • Price
  • WVE $7.79
  • SSYS $10.89
  • Analyst Decision
  • WVE Strong Buy
  • SSYS Strong Buy
  • Analyst Count
  • WVE 16
  • SSYS 3
  • Target Price
  • WVE $20.19
  • SSYS $14.33
  • AVG Volume (30 Days)
  • WVE 2.1M
  • SSYS 1.1M
  • Earning Date
  • WVE 11-11-2025
  • SSYS 11-12-2025
  • Dividend Yield
  • WVE N/A
  • SSYS N/A
  • EPS Growth
  • WVE N/A
  • SSYS N/A
  • EPS
  • WVE N/A
  • SSYS N/A
  • Revenue
  • WVE $93,946,000.00
  • SSYS $564,499,000.00
  • Revenue This Year
  • WVE N/A
  • SSYS N/A
  • Revenue Next Year
  • WVE $6.85
  • SSYS $3.06
  • P/E Ratio
  • WVE N/A
  • SSYS N/A
  • Revenue Growth
  • WVE N/A
  • SSYS N/A
  • 52 Week Low
  • WVE $5.28
  • SSYS $6.92
  • 52 Week High
  • WVE $16.74
  • SSYS $12.88
  • Technical
  • Relative Strength Index (RSI)
  • WVE 52.90
  • SSYS 48.42
  • Support Level
  • WVE $6.91
  • SSYS $10.52
  • Resistance Level
  • WVE $8.31
  • SSYS $12.25
  • Average True Range (ATR)
  • WVE 0.42
  • SSYS 0.47
  • MACD
  • WVE 0.15
  • SSYS -0.07
  • Stochastic Oscillator
  • WVE 69.65
  • SSYS 21.00

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

Share on Social Networks: